Evolution of the Average Target: Ipsen

Data source: Ipsen(IPN)

Evolution of the Target Price: Ipsen

Data source: Ipsen(IPN)

Changes in Analyst Recommendations: Ipsen

Data source: Ipsen(IPN)
4671b60eb489a7bfa40b846cf93cd01b.H3xf2q_2LOKW3-1lvWbecEyfK7ynJV6RV4O3NQiuU9E.R00-69-mfJqmsY5d7AjuGATKR9DFYg75MMrdDGmaZudxPxfqnsdjsMCP1Q~043a8bcbf64c15ae43cbee781a470c03
18/09 AlphaValue/Baader Europe Ups Price Target, Forecasts for Ipsen on 'Solid' H1 Performance MT
18/09 Ipsen: Incorporating solid H1 operational performance + guidance upgrade Alphavalue
18/09 Ipsen extends its pullback despite AlphaValue Zonebourse
20/08 Cancer vaccines finally garner the spotlight Alphavalue
17/08 Kepler Cheuvreux Boosts Ipsen PT, Maintains Hold Rating MT
03/08 Jefferies Downgrades Ipsen to Underperform, Boosts PT MT
30/07 Ipsen: Another quarterly beat; 2026 guidance upgraded Alphavalue
15/07 Where would AI lead Pharma in the long run? Alphavalue
07/07 AlphaValue/Baader Europe Cuts Ipsen Price Target Amid Future Patent Expiries, Mid-term Risks MT
06/07 Ipsen: Reassessing mid-term risks Alphavalue
01/07 AlphaValue/Baader Europe Downgrades Ipsen to Add, Lifts PT MT
01/07 Oddo BHF still neutral on Ipsen after a new acquisition Zonebourse
30/06 Ipsen Extends Its Rally, Backed by Oddo BHF Zonebourse
05/06 HC Wainwright Starts Ipsen Coverage with Buy Rating MT
28/05 Ipsen Price Target, Estimates Up as AlphaValue/Baader Europe Notes Upcoming Data Readouts, Product Mix MT
27/05 Ipsen: Beneficiary of favourable product mix and imminent readouts Alphavalue
24/04 Profit-taking hits Ipsen despite UBS price target hike Zonebourse
24/04 Ipsen: Opened the year with encouraging traction Alphavalue
14/04 Deutsche Bank raises price target on Ipsen Zonebourse
17/03 BNP Paribas Upgrades Ipsen to Neutral, Boosts PT MT
11/03 CIC Corporate & Institutional Banking Upgrades Ipsen to Buy, Boosts PT MT
13/02 Ipsen Remains in the Green with UBS Support Zonebourse
13/02 Ipsen: Markets applaud strong finish to 2025 and better-than-expected 2026 outlook Alphavalue
15/01 Ipsen, Top Gainer on the SBF 120 and SRD at Wednesday, January 14, 2026 Close Zonebourse
14/01 Ipsen and EMS-Chemie Shine on the Stock Market, Vistry and Pearson Struggle Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - -
+12.14%
+2.67%
+5.09%
+3.29%
+6.25%
- +28.98%
-4.14%
+5.99%
+21.56%
Average +9.09%
Weighted average by Cap. +8.55%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
143.30EUR
Average target price
165.40EUR
Spread / Average Target
+15.42%
High Price Target
235.00EUR
Spread / Highest target
+63.99%
Low Price Target
130.00EUR
Spread / Lowest Target
-9.28%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA